Cargando…
Analysis of early phase and subsequent phase III stroke studies of neuroprotectants: outcomes and predictors for success
BACKGROUND: Efficacy of neuroprotective treatments for ischemic stroke was not convincingly demonstrated in clinical phase III trials so far, whereas some preceding early phase studies found neuroprotection to be beneficial. We aimed to determine the frequency with which phase III studies are preced...
Autores principales: | Minnerup, Jens, Wersching, Heike, Schilling, Matthias, Schäbitz, Wolf Rüdiger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922860/ https://www.ncbi.nlm.nih.gov/pubmed/24502346 http://dx.doi.org/10.1186/2040-7378-6-2 |
Ejemplares similares
-
Erythropoietin for stroke treatment: dead or alive?
por: Minnerup, Jens, et al.
Publicado: (2011) -
EPO for stroke therapy - Is there a future for further clinical development?
por: Minnerup, Jens, et al.
Publicado: (2010) -
Late Onset Postpartum Eclampsia: It is Really Never Too Late—A Case of Eclampsia 8 Weeks after Delivery
por: Minnerup, Jens, et al.
Publicado: (2009) -
Effects of Different Exercise Strategies and Intensities on Memory Performance and Neurogenesis
por: Diederich, Kai, et al.
Publicado: (2017) -
Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats
por: Minnerup, Jens, et al.
Publicado: (2014)